Occipital Nerve Stimulation for Recurrent Trigeminal Neuralgia Without Occipital Pain.
Neuromodulation
occipital nerve stimulation
pain
surgery
trigeminal neuralgia
Journal
Neuromodulation : journal of the International Neuromodulation Society
ISSN: 1525-1403
Titre abrégé: Neuromodulation
Pays: United States
ID NLM: 9804159
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
14
11
2021
revised:
22
03
2022
accepted:
24
03
2022
pubmed:
11
6
2022
medline:
11
6
2022
entrez:
10
6
2022
Statut:
ppublish
Résumé
Trigeminal neuralgia (TN) is a severe, debilitating pain condition causing physical and emotional distress. Although the management of TN is well codified with medical and then surgical treatments, 15% to 30% of patients will experience intractable pain. Neuromodulation techniques have been scarcely used for refractory TN, with only small case series and short-term follow-up. We conducted a retrospective study of patients treated with occipital nerve stimulation (ONS) for medically and surgically resistant TN without painful trigeminal neuropathy. The effectiveness of the ONS was evaluated using the Barrow Neurological Institute (BNI) pain score and the pain relief (0%-100%) at best and at last follow-up. Seven patients who have refractory TN were included. The mean age at ONS was 49 years. The mean pain duration was 8.6 years. The mean number of medical and surgical treatments before ONS was six and five, respectively. A percutaneous trial was performed in five of seven patients; all responded (pain relief > 40%), and four of five patients experienced pain recurrence after explantation. Eventually, six patients had a permanent ONS implantation. The average BNI pain score before implantation was V. The mean follow-up after implantation was 59 months. All patients reported an improvement after implantation. The average BNI score and mean pain relief at best were IIIa and 86.7%, respectively. At last follow-up, the average BNI score and mean pain relief were IIIa and 58.0%, respectively, with three patients experiencing pain recurrence. Adverse events were reported for four patients who required surgical revision for lead breakage (1), erosion (1), migration (1), or hardware-related discomfort (1). One patient finally underwent explantation because of infection. Although ONS is not validated in this indication, these results suggest that it can induce an improvement in TN recurring after several surgical treatments, and the benefit of the stimulation can be sustained in the long term. The Clinicaltrials.gov registration number for the study is NCT01842763.
Identifiants
pubmed: 35688701
pii: S1094-7159(22)00649-3
doi: 10.1016/j.neurom.2022.03.012
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT01842763']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1795-1801Informations de copyright
Copyright © 2022 International Neuromodulation Society. Published by Elsevier Inc. All rights reserved.